These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 19121847

  • 1. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [Abstract] [Full Text] [Related]

  • 2. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B, Baekelandt M, Shih IeM.
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [Abstract] [Full Text] [Related]

  • 3. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
    Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B.
    Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
    [Abstract] [Full Text] [Related]

  • 4. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 5. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B.
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [Abstract] [Full Text] [Related]

  • 6. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
    Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA.
    Cancer; 2007 Sep 15; 110(6):1264-71. PubMed ID: 17647260
    [Abstract] [Full Text] [Related]

  • 7. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
    Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.
    Hum Pathol; 2011 Jul 15; 42(7):1019-26. PubMed ID: 21315408
    [Abstract] [Full Text] [Related]

  • 8. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M.
    Hum Pathol; 2000 Sep 15; 31(9):1081-7. PubMed ID: 11014575
    [Abstract] [Full Text] [Related]

  • 9. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov 15; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 10. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
    Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R.
    Gynecol Oncol; 2007 Feb 15; 104(2):311-9. PubMed ID: 17030350
    [Abstract] [Full Text] [Related]

  • 11. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV, Nesland JM, Davidson B.
    Am J Surg Pathol; 2006 Jul 15; 30(7):878-82. PubMed ID: 16819331
    [Abstract] [Full Text] [Related]

  • 12. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
    Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Jun 15; 40(6):795-806. PubMed ID: 19157506
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic role of claudins in serous effusions.
    Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B.
    Am J Clin Pathol; 2007 Jun 15; 127(6):928-37. PubMed ID: 17509990
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
    Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B.
    Am J Clin Pathol; 2009 Nov 15; 132(5):756-62. PubMed ID: 19846818
    [Abstract] [Full Text] [Related]

  • 15. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H.
    Clin Cancer Res; 2006 Feb 15; 12(4):1208-14. PubMed ID: 16489075
    [Abstract] [Full Text] [Related]

  • 16. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B, Shih IeM, Wang TL.
    Hum Pathol; 2008 Nov 15; 39(11):1630-6. PubMed ID: 18656238
    [Abstract] [Full Text] [Related]

  • 17. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec 15; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 18. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B, Dong HP, Holth A, Berner A, Risberg B.
    Breast J; 2008 Dec 15; 14(5):476-82. PubMed ID: 18657145
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities.
    Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B.
    Diagn Cytopathol; 2005 Nov 15; 33(5):332-7. PubMed ID: 16240397
    [Abstract] [Full Text] [Related]

  • 20. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
    Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA.
    Clin Cancer Res; 2003 Jun 15; 9(6):2248-59. PubMed ID: 12796393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.